While both IgG and IgA anti-toxin antibodies may confer protection against symptomatic C. difficile infection in the cystic fibrosis population, it is likely that the dominant functional neutralizing antibody effect is exerted by IgG, which is associated with more mature high-affinity responses. This evidence concerns the gene CD79A and cystic fibrosis.